New York, NY, November 11, 2009-Ebitda News reports that negative EBITDA for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for its quarter ended September 30, 2009 was $(26,290,000), a 31% improvement ove ... read full story
The indices continue to rally at midday, and stocks have seen their best one-day performance since July 2009 during this session after an easing of fears regarding sovereign debt issues in Europe. An earlier report today had indictated that the Euro ... read full story